Product
CART123 cells
1 clinical trial
4 indications
Indication
Acute Myeloid LeukemiaIndication
RelapseIndication
AdultIndication
RefractoryClinical trial
Phase 1 Study of Lentivirally Transduced T Cells Engineered to Contain Anti-CD123 Linked to TCRζ and 4-1BB Signaling Domains in Subjects With Refractory or Relapsed Acute Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2024-08-01